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Executive Summary 
 
Information on the acute mammalian toxicity of chemicals, referring to the adverse effects caused 
by either a single exposure to a chemical substance or multiple exposures within 24 hours, is 
required under multiple pieces of EU legislation aimed at protecting consumers and workers. 
Presently all regulatory methods for determining acute oral toxicity are based on animal tests. In 
these tests, the acute lethal dose to 50% of the treated animals (LD50 value) is typically used as the 
basis for hazard assessment and regulatory classification. The most widely used classification 
scheme is the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) 
system managed by the United Nations.  
 
Due to animal welfare and cost considerations, alternatives to animal experiments are being sought, 
and regulatory frameworks are increasing providing an opportunity or obligation to use such 
methods. Most of these alternatives are based on in vitro test methods or computational models 
such as Quantitative Structure-Activity Relationships (QSARs). To date, most studies have 
focussed on the abilities of individual in vitro tests or QSAR models to predict reference data from 
acute toxicity tests in rodents, with relatively few attempts to explore the combined use of in vitro 
and computational methods. 
 
In this study, we used a reference dataset of 180 compounds for which in vitro and in vivo data 
were already available from international validation studies in order to assess the abilities of five 
alternative approaches to predict acute oral toxicity. The in vitro data are considered to be of high 
quality, having been generated and quality controlled as part of the previous validation studies. The 
in vivo data showed considerable variability for some compounds, with about 20% of the 
compounds crossing two or three toxic classes. We included four QSAR models (ToxSuite, 
TOPKAT, TEST and ADMET Predictor), which were available in-house, and one in vitro method, 
the Neutral Red Uptake (NRU) basal cytotoxicity assay performed in a rodent cell line (BALB/3T3) 
and using the in vitro prediction model of Halle. We characterised the predictive performance of 
each alternative method when used alone (both for LD50 prediction and acute toxicity classification 
into three categories), as well as multiple test combinations (batteries) and stepwise testing 
strategies (for acute toxicity classification into three categories).  
 
When used individually, the alternative methods showed an ability to predict LD50 with correlation 
coefficients in the range from 49% to 84%, and to classify into three toxicity groups with accuracies 
in the range from 41% to 72%. Among the QSAR models, the best performing models were 
ToxSuite and TEST, with correlation coefficients of approximately 80% in LD50 prediction, and 
accuracies of approximately 70% in acute toxicity classification. The in vitro 3T3 NRU method, 
based on the use of the Halle prediction model, had a correlation coefficient with LD50 of 
approximately 50%, and a classification accuracy of approximately 41%. 
 
When the QSAR models were combined in batteries, the overall accuracies were between 62% and 
74%. While these figures are not much higher than the individual QSAR models alone, the 
sensitivities for the different toxic classes were considerably higher. On the other hand, the 
differences between the specificities for the different toxic classes were relatively small.   
 
When the alternative methods were used in a stepwise testing strategy the overall accuracy could 
reach 76%. Different test combinations could be used to optimise overall accuracy, sensitivity or 
specificity, according to the end-user's requirements. 
 
On the basis of our results, we conclude that: 
 
a) the variability in LD50 values has an impact on classification, which means that the use of 
average LD50 values as a reference standard has to be used with care.  
b) The 3T3 NRU in vitro test, used with the prediction model of Halle, has a lower predictive 
performance than the QSAR models. It is possible, however, that the in vitro test has a 
broader domain of applicability compared to the QSARs. It would be useful to explore 
whether the predictive performance of the in vitro system could also be increased by using 
an alternative prediction model. 
c) the overall accuracies for the test combinations (model batteries) or testing strategies are not 
much higher than the AMs used alone, but may be optimised in terms of overall predictivity, 
sensitivity and specificity according to the end-user’s requirements. 
 
Further studies, based on more extensive and high quality datasets (e.g. as generated by High 
Throughput Screening), would be valuable in the search for optimal strategies for assessing acute 
toxicity. 
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1 Background and objective of study 
 
1.1 Animal tests for acute oral toxicity 
 
Acute toxicity describes the adverse effects caused by either a single exposure to a chemical 
substance or multiple exposures within 24 hours. The acute lethal dose to 50% of the treated 
animals (LD50 value) is the basis for the hazard assessment and classification of chemicals and is 
widely used for regulatory purposes. Presently all accepted methods for regulatory requirements for 
determining acute oral toxicity are based on animal (in vivo) tests. There are three approved in vivo 
tests which are modifications of the classical median lethal dose, LD50 test (the Organisation for 
Economic Cooperation and Development (OECD) Test Guideline (TG) 401 (OECD, 1987), which 
was deleted in 2002. The three modified tests defined in the OECD TGs: 420 Fixed Dose Procedure 
(FDP), 423 Acute Toxic Class Method (ATC), and 425 Up and Down Procedure (UDP) (OECD, 
2001a,b,c) are utilizing the principles of reduction and refinement. These tests are sequential tests 
where the outcome of the previous step/dose determines the next dose to be tested and the number 
of animals used per test can then be considerably reduced (from 25 to a minimum of 5 animals per 
test). The FDP and the ATC identifies a lowest fixed dose causing evident toxicity and they provide 
estimated LD50 intervals whereas the UDP estimates a LD50 value. 
 
There are requirements of acute oral toxicity testing for agrochemicals, biocides and also for 
industrial chemicals. The acute toxicity testing in animals of cosmetic ingredients and products has 
been banned in the EU since 2009 (EC, 2003). For food additives, flavourings, food-contact 
materials, pharmaceuticals, and veterinary medical products there are no obligations for oral 
toxicity testing in EU (Seidle et al., 2010). 
 
 
1.2 The Globally Harmonised System of Classification and Labelling (GHS)  
 
The Globally Harmonized System of Classification and Labelling of Chemicals (GHS) is an 
internationally established system, implemented by the United Nations (UN, 2007). It is designed to 
replace the various classification and labelling standards used in different countries by using 
consistent criteria for classification and labelling on a global level. Two of the main purposes of the 
GHS have been to reduce the need for testing and evaluation of chemicals and to facilitate 
international trade in chemicals whose hazards have been properly assessed and identified on an 
international basis. 
 
The Classification, Labelling and Packaging (CLP) Regulation (EC No 1272/2008; EC, 2008) is the 
European Union regulation which aligns, since 2009, the European Union system of classification, 
labelling and packaging of chemical substances and mixtures to the GHS. It complements the 
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) Regulation (EC No 
1907/2006; EC, 2006) and replaces the system contained in the Dangerous Substances Directive 
(67/548/EEC; EC, 1967) and the Dangerous Preparations Directive (1999/45/EC; EC, 1999). For 
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oral acute toxicity, chemicals are classified in one of four toxicity categories based on their oral 
acute toxicity estimates, as illustrated in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Alternatives to animal testing and Integrated Testing Strategies 
 
Due to animal welfare and cost considerations, alternatives to animal experiments are being sought, 
and regulatory frameworks are providing an increasing opportunity or obligation to use such 
methods. The modified LD50 tests are still debated among toxicologists, animal welfare 
organizations, legislators and the public primarily due to the ethics of using animals for 
experimental purposes and evaluating mortality as an endpoint. The two major alternatives to in 
vivo animal testing are the in silico and the in vitro methods.  
 
According to the REACH chemicals legislation, Quantitative Structure-Activity Relationships 
(QSARs) can be used as alternatives to animal testing. QSAR models may identify chemical 
hazards and improve the safe use of chemicals.  Laboratory testing may be avoided by using QSAR 
models to predict chemical effects directly from chemical structure and simulating adverse effects 
in cells, tissues, laboratory animals and the environment. Estimation of LD50 values presents some 
drawbacks when used for QSAR modelling. First, acute toxicity effects may result from a wide 
spectrum of biokinetic, cellular and molecular events. Converting the complex, whole-body 
phenomena related to acute toxicity into a simple number necessarily leads to a loss of information. 
Figure 1. The CLP Regulation (EC No 1272/2008) for oral acute toxicity and the 
four acute toxicity hazard categories. 
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Second, available data are highly variable, having been generated by different laboratories, 
protocols, animal species and strains. This undermines the reliability and repeatability of acute 
toxicity measurements. These facts complicate the modelling process and may explain why there 
are relatively few QSAR models and expert systems for predicting oral acute toxicity, in 
comparison with other endpoints. An overview of the different QSAR models used in the 
assessment of acute systemic toxicity is given by Lapenna et al. (2010). 
 
In vitro cytotoxicity methods have been evaluated as alternatives to the use of animals in toxicity 
testing over the past four decades. Many international projects have evaluated the relationship 
between in vitro cytotoxicity and acute in vivo toxicity. The results of three major projects; MEIC 
(Multicentre Evaluation of In Vitro Cytotoxicity, Clemedson et al., 1996), the Halle RC (Registry 
of Cytotoxicity, Halle, 2003) and the NICEATM/ECVAM international validation study 
(NICEATM-ICCVAM, 2006) have all shown a linear correlation of around 60-70% between in 
vitro IC50 cytotoxicity data and oral rat LD50 values. For an overview of the use of in vitro 
cytotoxicity assays to predict acute oral toxicity see (NICEATM-ICCVAM, 2006). The OECD has 
established a Guidance Document (GD No 129; OECD, 2010) based on the outcome from the 
NICEATM/ECVAM validation study that describes how to estimate starting doses for acute oral 
systemic toxicity tests by first conducting cytotoxicity tests. 
 
In principle, QSARs or in vitro methods can be used as replacements for in vivo acute toxicity, 
tests, provided they are sufficiently validated. In practice, due to current limitations in predictive 
methods, both in silico and in vitro approaches are likely to be used in combination in the context of 
Integrated Testing Strategies (ITS), in order to replace, reduce or refine animal testing. The concept 
of ITS and its application to regulatory toxicology is discussed elsewhere (van Leeuwen et al., 
2007; Bassan et al., 2008). More generally, there is a trend in predictive toxicology to develop a 
new paradigm of toxicological assessment (“Toxicology in the 21st Century”) based on the 
integrated use of multiple methodologies, including computer-based modelling, high-throughput 
and high-content screening technologies (NRC, 2007; Collins et al., 2008; Dix et al., 2007). 
 
1.4 Objective of study 
 
In this study we investigate the predictive performances of five alternative approaches for the 
assessment of acute oral toxicity. We consider the ability of four QSAR models (ToxSuite, 
TOPKAT, TEST and ADMET Predictor) and one in vitro method (3T3 NRU using the prediction 
model of Halle) for prediction of LD50 values. The predictive performance of each method when 
used alone (both for LD50 prediction and acute toxicity classification into three categories), as well 
as multiple test combinations (batteries) and stepwise testing strategies (for acute toxicity 
classification into three categories are being calculated and compared. To assess the predictive 
performances of the alternative methods, a test set containing in vitro and in vivo data for 180 
compounds is being considered.  
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2 Materials and methods 
 
2.1 Acute Systemic Toxicity data set 
 
The data set in this study originates from three large alternative method studies. The studies are the 
following: 
 
(1) NICEATM/ECVAM international validation study (NICEATM-ICCVAM, 2006) 
(2) ACuteTox project (Acutetox, 2010)  
(3) ECVAM follow-up study (Kinsner-Ovaskainen et al., 2009) 
 
In the first study, the National Toxcicology Program Interagency Centre for the Evaluation of 
Alternative Toxicological Methods (NICEATM) and the European Centre for the Validation of 
Alternative Methods (ECVAM) conducted a joint validation study during 2002-2005 of the Neutral 
Red Uptake (NRU) basal cytotoxicity assay performed in two standard cell systems: a human cell 
system (normal human keratinocytes, NHK), and a rodent cell system (BALB/3T3 cell line). The 
study involved 72 chemicals, 12 chemicals from each GHS toxicity category, including non-
classified chemicals. Most of the chemicals were pharmaceuticals (35%), pesticides (22%), solvents 
(10%) or consumer/industrial products (5%). The results of this study showed that the overall 
accuracy of the 3T3 NRU test method for correctly predicting each of the GHS acute oral toxicity 
classification categories was only about 30%. 
 
The second study, “An In Vitro Test Strategy for Predicting Human Acute Toxicity” (Acutetox), 
was an integrated project within the sixth framework programme during 2005-2010. The main 
objective was to develop an in vitro test strategy sufficiently robust and powerful to replace in vivo 
testing of acute toxicity. The study involved 97 chemicals tested in diverse in vitro assays. Also in 
this study most of the chemicals were pharmaceuticals (52%), industrial products (31 %) or 
pesticides (12%). The study showed that by using a Random Forests model with seven in vitro 
assays and nine endpoints the classification rate was 69% (of classifying the chemicals classified 
into the official acute toxicity categories). 
 
The aim the third study was to assess the predictive capacity of a cytotoxicity test to determine if a 
test chemical correctly falls into one of the two categories, non-classified (LD50 > 2 000 mg/kg), or 
classified (LD50 ≤ 2000 mg/kg). The study involved 56 industrial chemicals tested with the NRU 
basal cytotoxicity assay performed in the rodent cell system (BALB/3T3 cell line) tested in three 
laboratories. The results (accuracy 64-67%, sensitivity 92-96% and specificity 40-44%) of this 
validation study showed that the 3T3 NRU test method can be regarded as a valuable test method to 
screen-out the negative test chemicals (unclassified) when the method is used as a first step in a 
tiered approach for acute oral toxicity testing.   
 
Forty five chemicals are duplicates in studies (1) and (2), so the total number of chemicals is 180 in 
the complete data set (see Annex). 26 chemicals in the complete data set are inorganic compounds 
or salts. Inorganic and organometallic compounds, salts, and compound mixtures are often removed 
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prior to QSAR analysis because many software tools for calculating chemical descriptors are not 
suitable for these molecules, because molecular graphs for these substances are not defined. 
 
In vivo data databases containing LD50 values had been produced for each study, so no new animal 
in vivo tests were performed. The chemicals selected in the studies were chosen to represent the 
complete range of in vivo acute oral toxicity ranges and are relevant with regard to human exposure 
potential. Principal sources of LD50 data, supported by original references, were internet databases, 
e.g. ChemIDplus and the Hazardous Substances Data Bank (HSDB). For our study only rodent (for 
175 of 180 chemicals rat and for the other mouse) data was considered with the oral administration 
route (administration by gavage (stomach tube) was regarded as equivalent to oral). The data set is 
very heterogeneous when it comes to sample size for the compounds, as can be seen in Figure 2. 
The sample size varies from one to 28 observations per compound. About one fifth of the 
compounds (40 compounds) have only one observation. The majority of the compounds have three 
or fewer observations. 
 
 
Figure 2. Sample size for Acute Systemic Toxicity data set. 
 
2.2 Analysis based on average LD50 values 
 
Figure 3 shows a scatter plot of the LD50 values for the 180 compounds. The compounds are 
ordered according to average LD50 (blue dots), starting with the most toxic (lowest LD50) compound 
to the left to the least toxic (highest LD50) compound to the right. The GHS category borders have 
also been inserted in the figure. More than one third of the compounds are crossing two GHS 
categories or even three GHS categories.  
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Figure 3. Scatter plot of the LD50 values for the 180 compounds. 
 
The number of compounds based on average LD50 which fall in the different GHS categories is 
shown in Figure  4 below. 
 
 
Figure 4. The number of compounds based on average LD50 which fall in the different GHS 
categories. GHS NC (non-classified) means compounds which have an LD50 above 2000 mg/kg. 
 
2.3 Comparison of CLP and average LD50 classifications 
 
67 of the 180 chemicals have official classifications for acute oral toxicity in Table 3.1, Annex VI 
to Regulation EC 1272/2008 CLP Regulation (EC, 2008). Another 27 chemicals are classified in 
the table according to acute dermal, acute inhalation toxicity, reproductive toxicity, aquatic toxicity 
or carcinogenicity.  
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Figure 5 shows how the 67 compounds are actually classified in the CLP Regulation compared with 
average LD50 classifications according to the GHS system. NC in the table stands for “non-
classified” and refers to compounds which have an average LD50 > 2000 mg/kg.  
 
 
Figure 5. Comparison of actual CLP, blue bars and average LD50  
classifications (red bars) for 67 chemicals. 
 
43 of 67 compounds are classified in the same category. In 8 cases the average LD50 category is 
lower than the CLP Regulation classification. In 16 cases the average LD50 category is higher than 
the CLP Regulation classification. In these cases the difference in category is one, apart from two 
cases. Table I  lists these two extreme cases.     
 
Table I. Compounds where the CLP and average LD50 classifications in                                         
the GHS diverge with more than one category. 
Chemical JRC 
number 
CAS 
number 
CLP 
GHS classification 
Average LD50 
GHS classification 
Methanol JRC-000019 67-56-1 3 NC 
Carbon 
tetrachloride 
JRC-000257 56-23-5 3 NC 
 
Methanol (JRC-000019, CAS number 67-56-1) is classified in the GHS category 3 in the CLP 
Regulation and in the NC (not classified) category for the average LD50 method. The sample of 
methanol LD50 values has 15 observations, with an average of 9591 mg/kg and a standard deviation 
of 2566 mg/kg. Also carbon tetrachloride (JRC-000257, CAS number 56-23-5) is classified in the 
GHS category 3 in the CLP Regulation and NC (not classified) category for the average LD50. The 
sample of LD50 values contains 17 observations, with an average of 4219 mg/kg and a standard 
deviation of 2099 mg/kg. These average LD50 values differ greatly from the cut-off in GHS 
category 3, 300 mg/kg. Differences for these two compounds could be due to volatility. 
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2.4 Definition of Toxic Classes  
 
We introduce our definition of Toxic Classes (TC), namely a grouping of the GHS categories 1 to 3 
into TC1, GHS category 4 into TC2 and taking the compounds which are not classified in the GHS 
system (that are compounds which have LD50 above 2000 mg/kg) into TC3. The three classes 
contain roughly the same number of chemicals. 55 chemicals fall in the first class, 60 in the second 
and 65 chemicals in the third class (Figure 6). 
 
 
Figure 6. The number of compounds based on average LD50 which fall in the different TCs. 
About 20% of the compounds cross two or three (in two cases) toxic classes. The compounds that 
cross three toxic classes are malathion (JRC-000012, CAS number 121-75-5, with 17 LD50 
observations in the range from 200 to 5800 mg/kg bodyweight) and phenytoin (JRC-000028, CAS 
number 57-41-0, with 3 LD50 observations in the range from 250 to 2200 mg/kg bodyweight).  
Figure  7 shows a scatter plot of the LD50 values for the 180 compounds with the TC borders. 
 
Figure 7. Scatter plot of the LD50 values for the 180 compounds with the TC borders. 
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2.5 Distribution of log LD50 
 
The distribution of log LD50 values is not symmetric but negatively (or left) skewed and the 
Generalised Extreme Value (GEV) distribution fits the data reasonably well. Figure 8 illustrates 
this, the empirical and the fitted GEV probability density functions to the left and the GEV 
probability plot to the right. The probability density function for the GEV distribution with location 
parameter µ, scale parameter σ, and shape parameter k ≠ 0 is 
          (Eq. 1) 
For 
                          (Eq. 2) 
 
 
 
 
 
 
 
 
 
 
 
2.6 QSAR software models for predicting rodent oral acute toxicity 
 
We have used four QSAR software tools to predict rat oral LD50, three commercial solutions and 
one freely available solution. The four QSAR tools are:  
 
1. ACD/Tox Suite, version 2.95 
2. Accelrys/TOPKAT (Toxicity Prediction by Komputer Assisted Technology), version 6.2 
3. U.S. EPA/ T.E.S.T. (Toxicity Estimation Software Tool), version 4.0 
4.  ADMET Predictor, version 5.5 
 
The first software, ACD/Tox Suite (TOXS), predicts potential toxicity (LD50) in two species 
(mouse and rat) for various administration routes (intraperitoneal, intravenous, subcutaneous, and 
oral administrations). The module “Acute Toxicity (LD50, Rat/Oral)” has been used. Predictions are 
based on a combination of expert knowledge of various basal and extra-cellular effects (e.g., 
inhibition of cholinesterase and ATP synthesis, CNS and PNS disruption), and SAR/QSAR analysis 
of more than 100,000 compounds. Predictions are provided with reliability estimations (reliability 
index). Compounds are classified into one of 5 toxicity categories (corresponding to the GHS 
categories).  
 
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
Data
 
 
D
en
si
ty
log10 LD50
Gen extreme value dist
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5
0.001 
0.005 
0.01  
0.05  
0.1   
0.25  
0.5   
0.75  
0.9   
0.95  
0.99  
0.995 
0.999 
0.9995
0.9999
Data
P
ro
ba
bi
lit
y
 
 
log10 LD50
Gen extreme value dist
Figure 8. (a) left, shows the empirical and the fitted GEV probability density functions.  (b) 
right, illustrates the GEV probability plot. 
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The second software, Accelrys/TOPKAT (TOPK), assesses the toxicity of chemicals solely from 
their 2D molecular structures and uses a range of robust, cross-validated Quantitative Structure-
Toxicity Relationship (QSTR) models for assessing specific toxicological endpoints. The model 
“Rat Oral LD50” has been used.  
 
The freely available software U.S. EPA/ T.E.S.T. (TEST) includes models for estimating toxicity 
for several endpoints using different QSAR methodologies. The model “Oral rat 50% lethal dose” 
was applied for this comparison study.  
 
The fourth software, the ADMET (Absorption, Distribution, Metabolism, Elimination and Toxicity) 
Predictor (ADMET) can be used for predictive modeling of ADMET properties. The toxicity 
module “Acute toxicity in rats” has been applied. These software tools are further described in 
Lapenna et al. (2010). 
 
2.7 An in vitro assay for predicting rodent oral acute toxicity 
 
From the three alternative method studies (Section 2.1 above), in vitro data have been generated 
from the Neutral Red Uptake (NRU) cytotoxicity assay. It is a cell survival/viability 
chemosensitivity test based on the ability of viable cells to incorporate and bind the supravital dye 
neutral red (NICEATM-ICCVAM, 2006). One of the cell models used in the studies was the CCL-
163, 3T3 BALB/c immortalised mouse fibroblast, cell line, clone 31 from the American Type 
Culture Collection (ATCC, Manassas, VA., USA). The in vitro assay and cell model will be 
referred to the 3T3 NRU test method.  
 
For 7 out of the 180 chemicals the 3T3 NRU test method did not yield the result of an IC50 value, 
mainly because of solubility problems. The problematic chemicals were the inorganic compound 
ferrous sulfate (JRC-000018, CAS number 7720-78-7), pentobarbital sodium (JRC-000030, CAS 
number 57-33-0), diphenhydramine (JRC-000033, CAS number 58-73-1), 1,3,5-trioxane, 2,4,6-
trimethyl-, paraldehyde (JRC-000038, CAS number 123-63-7), acrylamide (JRC-000040, CAS 
number 79-06-1 ), acetaldehyde (JRC-000042, CAS number 75-07-0) and carbon tetrachloride 
(JRC-000257, CAS number 56-23-5). 
 
From Study 1 (NICEATM-ICCVAM, 2006) the in vitro data originate from three laboratories: the 
U.S. Army Edgewood Chemical Biological Center (ECBC, USA), the Institute for In Vitro 
Sciences (IIVS, USA) and the FRAME Alternatives Laboratory (FAL, UK). The in vitro data in 
Study 2 (Acutetox, 2010) come from three laboratories: FAL, the Advanced In Vitro Cell 
Technologies, (Advancell, Spain) and from our robotic HTS laboratory (IHCP, JRC, Italy). From 
Study 3 (Kinsner-Ovaskainen et al., 2009) the in vitro data come from the Health and Safety 
Laboratory (HSL, UK), the IIVS and from the JRC-IHCP HTS laboratory.  
 
Figure 9 shows a scatter plot of the IC50 values for the 173 compounds from the three studies. The 
compounds are ordered according to average IC50 (blue dots), starting with the most cytotoxic 
(lowest IC50) chemical to the left to the least cytotoxic (highest IC50) compound to the right. 
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Figure 9. Scatter plot of IC50 values for the 173 compounds. 
The conclusion from the NICEATM/ECVAM Validation Study was that the 3T3 NRU test method 
was not good enough for classifying the test compounds in the different hazard categories but could 
be used to aid in setting the starting dose for sequential rodent acute oral toxicity test methods.  
 
2.8 Evaluation of the predictive capacity of an alternative methods 
 
The predictive capacity of an alternative method (a QSAR software prediction or an in vitro assay) 
is frequently expressed by comparing the results obtained with the alternative method being tested 
on a sample of chemicals with the results of reference values on the same chemicals where the 
reference test results are taken as the true values. We assume that our true reference values are the 
rodent oral acute toxicity data, the average LD50 values.  
 
In the simple case when the test method being evaluated and reference values are expressed with a 
binary outcome (positive or negative), the result of the test method study can be displayed in a 2 x 2 
contingency table whose columns represent the reference results and whose rows represent the test 
method results. The 2 x 2 contingency table displaying the results of test method studies are often 
summarised by various characteristics of the test method and the population of chemicals. In 
medical and toxicological applications they are sometimes referred to as “Cooper statistics” 
(Cooper et. al, 1979). In our case, we have an extension of the binary classification since we have 
three toxic classes (TC1, TC2 and TC3) and hence 3 x 3 contingency tables, see Table II and Table 
III for the definitions of three main Cooper statistics.  
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Table II.  A 3 x 3 contingency table 
 
             
    In vivo Ref Class   Row  
    TC1 TC2 TC3   Totals 
Predicted TC1 a b c   nR1 
 Class TC2 d e f   nR2 
 TC3 g h i   nR3 
              
Column Totals   nC1 nC2 nC3   n 
            
Grand 
Total 
             
 
 
Table III. Definitions of three main Cooper statistics for 3 x 3 contingency tables 
Statistic Definition Calculation 
Accuracy 
(concordance) 
The proportion of chemicals that the test 
method classifies correctly 
(a+e+i)/n 
Sensitivity for TC1 
chemicals 
The proportion of chemicals that are 
classed in TC1 in vivo which the 
alternative method predicts to be in TC1 
a/nC1 
Specificity for TC1 
chemicals 
The proportion of chemicals that are 
classed in TC2 or T 3 in vivo which the 
alternative method predicts to be in TC2 
or TC3 
(e+h+f+i)/(nC2+nC3) 
For TC2 and TC3 chemicals the calculations are made in corresponding way 
 
 
Sensitivity and specificity can also be easily calculated with Bayes’ theorem (also called the inverse 
probability law). The sensitivity for TC1 chemicals is the probability that the test method predicts 
chemicals to be in TC1 given that the chemicals are really in that class. 
 
             (Eq. 3) 
 
where AM stands for alternative method class and REF stands for reference class. The specificity 
for TC1 chemicals is the probability that the software program predicts chemicals to be in TC2 or 
TC3 given that the chemicals are really in those classes. 
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… 
 
               (Eq. 4) 
 
For TC2 and TC3 chemicals the calculations are made in corresponding way. 
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3 Results 
 
3.1 QSAR software prediction results 
 
In the subsequent analysis the 26 inorganic compounds and salts have been removed from the 
complete data set. The total number of compounds in the remaining data set is thus 180-26=154. 
Figure 10 illustrates the scatter plots of the LD50 values in the data set and the results from the 
QSAR software predictions. There seems to be a trend for all four QSAR software that, for more 
toxic chemicals (for TC1 chemicals) the programs overestimate the LD50 (hence underestimate the 
toxicity) and for less toxic chemicals (for TC3 chemicals) the programs underestimate the LD50 
(overestimate the toxicity). For the compounds in between there is no trend.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A nonparametric statistical method is applied to look at these differences. Few assumptions about 
the form of the distributions are made. The three TCs will be tested separately and the sample sizes 
are 43 compounds in TC1, 53 compounds in TC2 and 58 compounds in TC3 taken from the 
reference LD50 data set. We assume that the data from the ith QSAR software form a random 
sample from a continuous cumulative distribution function Fi, i = 1, …, 5 (including the reference 
LD50 data set) and the random samples are mutually independent. Therefore, the following null and 
alternative hypotheses to be tested are: 
 
H0: F1 = F2 = …= F5 vs. H1: Fi < Fj for some i ≠ j.       (Eq. 5) 
 
The ranking test called Kruskal-Wallis is applied for each of the three TCs and show the difference 
between the methods is significant for 1 and TC3 but not for TC2. This fact can also be seen in 
Figure 11, which depicts the boxplots of the LD50 distributions for the reference data and the four 
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Figure 10. Scatter plots of LD50 values and the QSAR software predictions. 
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QSAR software programs for each toxic class. For the distributions of TC1 and TC3, all pairwise 
differences between the reference LD50 and the 4 QSAR software are significant (using a method to 
control Type I family wise error (FWE) rate) but not between all QSAR-methods. 
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Figure 11. Boxplots of the LD50 distributions for the reference data (REF) and the 4 QSAR 
software programs (TOXS, TOPK, TEST, ADMET) for each TC (1, 3 and 2). The difference 
between the methods (REF and QSAR software) is significant for TC1 and TC3 but not for TC2. 
 
Figure 12 illustrates scatter plots of the reference LD50 values versus the 4 QSAR software 
predictions on a 10-log scale. The strongest linear relationship (the Pearson correlation coefficient 
is ρ = 0.84) between the predictions of the TOXS software and the reference LD50 values. The 
predictions of TOPK and the reference LD50 values have the lowest correlation (ρ=0.49). 
 
 
Figure 12. Scatter plots of the predicted LD50 values from the 4 QSAR software tools versus the 
reference LD50 values on a 10-log scale. 
ρ=0.84 ρ=0.49 
ρ=0.80 ρ=0.67 
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3.2 In vitro assay prediction results  
 
To obtain the predicted LD50 values from the IC50 values (μg/ml) from the in vitro test experiments, 
the regression models from the Halle RC (RC reg) were used: 
 
Millimole regression model: log LD50 (mmol/kg) = 0.439· log IC50 (mM) + 0.621  (Eq. 6) 
 
Weight regression model: log LD50 (mg/kg) = 0.372 ·log IC50 (μg/mL) + 2.024  (Eq. 7) 
 
Figure 13 illustrates a scatter plot of the predicted LD50 values from the weight regression model 
(Eq. 7) versus the reference LD50 values on a 10-log scale. Most compounds in the regression 
model are classified in the middle toxic class and few compounds are classified in the most and 
least toxic classes. The correlation coefficient is 0.53.  
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Figure 13. Scatter plots of the predicted LD50 values versus the                                                 
reference LD50 values on a 10-log scale. 
3.3 Evaluation of the predictive capacity of an alternative test method 
 
The heat map in Figure 14 gives a graphical representation of the five alternative test method 
predictions, in columns 2 - 6, compared to the reference LD50 values, in column 1. The compounds 
are ordered in decreasing toxicity of the reference values. The compounds that are classified in TC1 
are in red, TC2 compounds in yellow and TC3 compounds in green. The software TOPK (column 
3) was not able to predict a LD50 value for the compound fentin hydroxide (JRC-000241, CAS 
number 76-87-9) and this compound is therefore grey coloured. For the RC reg predictions (column 
6) there are six grey compounds corresponding to the six inorganic problematic chemicals listed in 
Section 2.7.  From an overview of these results we make some observations: 
 
- the worst classification error of predicting TC1 chemicals in the TC3 is made by the TOPK 
software six times and by the TEST software twice, 
- the TOXS and TEST software tools seem to yield similar and the best results (apart from the 
two TC1 errors), 
- the ADMET software and the RC reg tend to predict chemicals in class TC2. 
   ρ=0.53
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Figure 14. Heat map of the alternative method predictions (columns 2-6)                                      
compared to the reference LD50 values (column 1). 
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We also calculated the accuracy, sensitivity and specificity for the five alternative test methods. 
Table IV and Table V go through the calculations of these statistics for one of the methods, the 
TOXS software (column 2). The accuracy is relatively high, 72%. The sensitivity for TC2 is higher 
that the sensitivities for TC1 and TC3 which are almost the same (81% compared to 67% in the 
other two cases). As a consequence, the specificities for TC1 and TC3 are almost the same and very 
high (95% and 94%) and larger than the specificity for TC2 (69%). 
 
Table IV. The 3 x 3 contingency table with the results from the TOXS software compared to the 
reference LD50 values. 
Software TOXS            
    In vivo Ref Class   Row  
    TC1 TC2 TC3   Totals 
Predicted TC1 29 4 2   35 
Class TC2 14 43 17   74 
  TC3 0 6 39   45 
              
Column Totals   43 53 58   154 
            
Grand 
Total 
              
 
 
Table V. Calculations of the accuracy, sensitivity and specificity for the TOXS software.  
 
Accuracy       (29+43+39)/154  ≈ 72.1% 
  TC1 29/43 ≈ 67.4% 
Sensitivity for TC2 43/53 ≈ 81.1% 
  TC3 39/58 ≈ 67.2% 
  TC1 (43+6+17+39)/(53+58) ≈ 94.6%
Specificity for TC2 (29+0+2+39)/(43+58) ≈ 69.3% 
  TC3 (29+14+4+43)/(43+53) ≈ 93.8%
 
 
Table VI gives an overview of the predictive capacities of the five alternative methods. TOXS has 
the highest accuracy, which can also be seen in the heat map in Figure 14. It also had the highest 
correlation coefficient for the individual predicted values, as can be seen in section 3.1. TEST has 
the second highest accuracy (68%), followed by TOPK (63%) and ADMET (57%). The RC reg 
model has the lowest accuracy, only 41%.  
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Table VI. Overview of the predictive capacity for the five alternative methods. 
 
  
Alternative 
Test Method 
TOXS TOPK TEST ADMET RC reg 
 Accuracy  72.1% 63.4% 68.2% 56.5% 40.5% 
    TC1 67.4% 55.8% 67.4% 41.9% 22.0% 
  Sensitivity for  TC2 81.1% 69.2% 79.2% 75.5% 72.0% 
    TC3 67.2% 63.8% 58.6% 50.0% 26.3% 
    TC1 94.6% 88.2% 93.7% 89.2% 85.0% 
  Specificity for  TC2 69.3% 70.3% 65.3% 50.5% 26.5% 
    TC3 93.8% 86.3% 92.7% 94.8% 100.0% 
 
Figure 15 illustrates the sensitivities and specificities for the five alternative test methods: 
 
- for all methods the sensitivities for TC2 are higher than for TC1 and TC3. Thus the 
specificities for TC2 for all methods are lower than for TC1 and TC3, 
-  the Cooper statistics for TOXS and TEST are similar, 
-  for the RC reg the specificity for TC3 is 100%, meaning that there are no misclassified TC3 
chemicals in the groups TC1 and TC2, but the sensitivity for TC3 is only 26%. 
 
 
 
 
Figure 15. Sensitivity and specificity for the five alternative test methods. 
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3.4 Combination of QSAR predictions  
 
In this section we combine the predictions from the different QSAR models and use the information 
to draw conclusions from a combined testing scheme. Ten different test batteries were chosen, as 
described in Table VII.  
 
Table VII. Descriptions of the different ways of combining QSAR predictions (test combinations) 
 
Abbr Description 
C1 The most conservative classification (TC) was picked among the 
four software tools. 
C2 The most conservative classification (TC) was picked among the 
three software; TOXS, TOPK and TEST. 
C3 The most common classification (TC) was picked among the 
four software tools. When the result is ambiguous (two 
classifications in two TC), the result is left blank. 
C4 The most common classification (TC) was picked among the 
four software tools. When the result is ambiguous (two 
classifications in two TC), the most conservative classification 
(TC) was chosen. 
C5 The most common classification (TC) was picked among the 
three software tools; TOXS, TOPK and TEST. When the result is 
ambiguous (one classification in each TC), the result is left 
blank. 
C6 The most common classification (TC) was picked among the 
three software tools; TOXS, TOPK and TEST. When the result is 
ambiguous (one classification in the each TC), the most 
conservative classification (TC) was chosen. 
C7 For TOXS, TOPK and TEST, an average LD50 was calculated and 
the TC assigned thereafter. 
C8 For TOXS and TEST, an average LD50 was calculated and the TC 
assigned thereafter. 
C9 The most conservative classification (TC) was picked among the 
two software TOXS and TEST. 
C10 The least conservative classification (TC) was picked among the 
two software TOXS and TEST. 
 
Figure 16. Accuracy, sensitivity and specificity for ten different test combinations (C1-C10). 
 
A heat map of the results is given in Figure 17. 
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Figure 17. Heat map of the test combinations (C1-C10) compared to the reference LD50 values 
(REF). For the test combinations C3 and C5, 25 and 8 ambiguous (inconclusive) results were found 
(white compounds), thus the adjusted number of chemicals in these test sets is 131 and 148. 
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Figure 18 depicts a scatter plot of the accuracy, sensitivity and specificity for the ten combinations 
of alternative methods. The complete list of statistics are given in Table VII. The accuracy lies 
between 62-74%. The test combinations C1 and C2 are good at identifying TC1 chemicals (the 
sensitivities for TC1 chemicals are 93% in both cases), since they are conservative methods. The 
trade-off is that they are bad at identifying low toxicity chemicals (the sensitivities for TC3 
chemicals are only 35% and 40%). A comfort is that when these test batteries pick out TC3 
chemicals we can be sure they really are low toxicity chemicals (the specificities for TC3 chemicals 
are 100% and 99%, respectively). The test combinations C7 and C8 are good at identifying TC2 
chemicals (the sensitivities are in both cases 87%). The test combination C10 is good at identifying 
TC3 chemicals with a sensitivity and specificity of 78% and 89%, respectively. 
 
 
 
Figure 18. Accuracy, sensitivity and specificity for ten different test combinations (C1-C10). 
 
 
23 
 
Table VIII. Predictive performance statistics for the ten test combinations (C1-C10). 
 
Alternative 
Method 
 
C1 
 
C2 
 
C3 
 
C4 
 
C5 
Accuracy   62.3% 66.2% 72.1% 68.2% 73.5% 
  TC1 93.0% 93.0% 64.7% 72.1% 70.0% 
Sensitivity for  TC2 67.9% 73.6% 85.4% 83.0% 82.4% 
  TC3 34.5% 39.7% 63.8% 51.7% 67.9% 
  TC1 77.5% 83.8% 93.7% 91.9% 93.5% 
Specificity for  TC2 67.3% 67.3% 65.4% 62.4% 70.8% 
  TC3 100.0% 99.0% 97.6% 97.9% 95.6% 
Alternative     
Method 
 
C6 C7 C8 C9 C10 
Accuracy   72.1% 72.7% 73.4% 69.5% 70.8% 
  TC1 72.1% 51.2% 60.5% 83.7% 51.2% 
Sensitivity for  TC2 79.2% 86.8% 86.8% 81.1% 79.2% 
  TC3 65.5% 75.9% 70.7% 48.3% 77.6% 
  TC1 90.1% 95.5% 96.4% 91.0% 97.3% 
Specificity for  TC2 72.3% 71.3% 68.3% 65.3% 69.3% 
  TC3 95.8% 91.7% 94.8% 97.9% 88.5% 
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3.5 Integrated testing strategies 
 
By using the methodology of ITS, we combine both the in silico and in vitro approaches presented 
in this report. In total, ten different ITS were investigated, as described in Table IX and illustrated 
by the heat map in Figure 20. The main predictive performance statistics are illustrated in Figure 
21, and detailed in full in Table X. 
 
 
Table IX. Description of ten different ITS. An explanation of the structure in the table, for ITS1, 
first the test combination C2 is applied to identify TC1 chemicals. Then the RC reg model is used to 
identify TC2 chemicals and finally the chemicals which are left are classified as TC3 chemicals. 
 
Abbr. Description Abbr. Description 
1. C2 (TC1 chemicals) 1. C10 (TC3 chemicals) 
2. RC reg (TC2 chemicals) 2. C9 (TC2 chemicals) ITS1 
3. TC3 chemicals 
ITS6 
3 TC1 chemicals 
1. C2 (TC1 chemicals) 1. C8 (TC2 chemicals) 
2. C9 (TC2 chemicals) 2. C2 (TC1 chemicals) ITS2 
3. TC3 chemicals. 
ITS7 
3 TC3 chemicals 
1. C2 (TC1 chemicals) 1. C9 (TC2 chemicals) 
2. C8 (TC2 chemicals) 2. C8 (TC3 chemicals) ITS3 
3. TC3 chemicals. 
ITS8 
3 TC1 chemicals 
1. C8 (TC3 chemicals) 1. C2 (TC1 chemicals) 
2. C9 (TC2 chemicals) 2. C10 (TC3 chemicals) ITS4 
3. TC1 chemicals 
ITS9 
3 TC2 chemicals 
1. C10 (TC3 chemicals) 1. C10 (TC3 chemicals) 
2. C8 (TC2 chemicals) 2. C2 (TC2 chemicals) ITS5 
3 TC1 chemicals 
ITS10
3 TC1 chemicals 
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Figure 20. Heat map of ten ITS (ITS1-ITS10) compared to the reference LD50 values (REF). 
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Figure 21. Scatter plots of accuracy, sensitivity and specificity for ten ITS. 
 
Table X. Overview of the predictive capacity for ten ITS (ITS1-ITS10). 
Alternative           
Method ITS1 ITS2 ITS3 ITS4 ITS5 
Accuracy   58.0% 68.8% 76.0% 76.0% 72.7% 
  TC1 93.0% 93.0% 93.0% 81.4% 60.5% 
Sensitivity for  TC2 62.0% 71.7% 69.8% 77.4% 77.4% 
  TC3 28.1% 48.3% 69.0% 70.7% 77.6% 
  TC1 83.2% 83.8% 83.8% 91.0% 96.4% 
Specificity for  TC2 61.0% 72.3% 84.2% 78.2% 73.3% 
  TC3 93.5% 97.9% 96.9% 94.8% 88.5% 
Alternative           
Method ITS6 ITS7 ITS8 ITS9 ITS10 
Accuracy   76.0% 73.4% 68.8% 75.3% 76.0% 
  TC1 81.4% 62.8% 81.4% 93.0% 90.7% 
Sensitivity for  TC2 69.8% 86.8% 81.1% 62.3% 62.3% 
  TC3 77.6% 69.0% 48.3% 74.1% 77.6% 
  TC1 91.9% 94.6% 91.0% 83.8% 87.4% 
Specificity for  TC2 83.2% 68.3% 65.3% 88.1% 88.1% 
  TC3 88.5% 96.9% 969% 91.7% 88.5% 
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For illustrative purposes, we present in details just two of the 10 ITS. Figure 22 illustrates the work 
flow of the first ITS. The test combination C2, presented in the previous section, is used in the first 
step, since it was shown to be good at picking out toxic chemicals (TC1). The sensitivity and 
specificity for this test combination for TC1 chemicals were 96% and 84%, respectively. We use 
this property and begin by identifying TC1 chemicals using the test combination C2. For the 
remaining chemicals, predicted either as TC2 or TC3 chemicals, we use the in vitro method RC reg 
to identify TC2 chemicals. For this method the sensitivity was 72% for TC2 chemicals. The 
remaining chemicals in the set are predicted to be low toxic chemicals, in TC3. The total number of 
chemicals is reduced to 152 since the in vitro method did not produce experimental results for all 
chemicals. The overall accuracy for ITS1 is 58%, considerably higher than the accuracy of the in 
vitro test alone (41%) but lower than the individual QSAR tests (63-72%). The high sensitivity and 
specificity for TC1 chemicals is preserved from the combined test C2 (93% and 83%), the statistics 
for TC2 chemicals are lower (62% and 61%). For TC3 chemicals the sensitivity is only 28% while 
the specificity is 93%.  
 
 
 
Figure 22. Work flow for ITS1; first the test combination C2 is applied to identify  
TC1 chemicals, then the RC reg model is used to identify TC2 chemicals and finally 
the chemicals which are left are predicted to be TC3 chemicals. 
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For ITS3, which is illustrated in Figure 23, the test combination C2 is first applied to identify TC1 
chemicals. Then the test combination C8 is used to identify TC2 chemicals and the chemicals which 
are left are predicted as TC3 chemicals. For this combination the overall accuracy is relatively high 
(76%). The Cooper statistics for TC2 and TC3 chemicals are higher than for ITS1 (the sensitivity is 
70% in both cases and the specificity is 84%, and 97%, respectively). 
 
 
 
Figure 23. Work flow for ITS3; first the test combination C2 is applied to identify  
TC1 chemicals, then the test combination C8 is used to identify TC2 chemicals and finally 
 the chemicals which are left are predicted to be TC3 chemicals. 
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4 Discussion and conclusions 
 
In this study, we have investigated the predictive performances of five alternative approaches for 
the assessment of acute oral toxicity, a toxicological endpoint required in multiple pieces of 
legislation on chemicals and consumer products. In particular, we investigated the ability of four 
QSAR models (ToxSuite, TOPKAT, TEST and ADMET Predictor) and one in vitro method (3T3 
NRU using the prediction model of Halle, RC reg). We characterised the predictive performance of 
each method when used alone (both for LD50 prediction and acute toxicity classification into three 
categories), as well as multiple test combinations (batteries) and stepwise testing strategies (for 
acute toxicity classification into three categories). To assess the predictive performances of the 
alternative methods, we compiled a test set containing in vitro and in vivo data for 180 compounds. 
The in vitro data are considered to be of high quality, being derived from international validation 
studies on in vitro tests.  
 
In the assessment of QSAR model performance, it should be noted that the statistics for predictivity 
do not reflect full external predictivity, since the test chemicals had been included to some extent in 
the training sets of one or more of the models. For consistency in the model comparisons, it was 
decided not to exclude any training set chemicals, since this is only partially known for the QSAR 
models. Similarly, the in vitro prediction model had been calibrated by using data for some of the 
test chemicals, but these were not excluded when assessing the performance of the in vitro 
prediction model (RC reg). 
 
The in vivo data showed considerable variability for some compounds. About 20% of the 
compounds cross two or three (in two cases) toxic classes. The compounds that cross three toxic 
classes are malathion (JRC-000012, CAS number 121-75-5) and phenytoin (JRC-000028, CAS 
number 57-41-0).  Sixty seven of the 180 chemicals have official classifications for acute oral 
toxicity in Table 3.1, Annex VI to Regulation EC 1272/2008 CLP Regulation (EC, 2008). When 
comparing the actual CLP classification with classifications derived from the average LD50 values 
according to the GHS system, we found that in 43 cases the chemicals are classified in the same 
category, in 8 cases the average LD50 category was lower than the CLP Regulation classification 
and in 16 cases the average LD50 category was higher than the CLP Regulation classification. In 
these cases the difference in category was one, apart from two cases, for methanol (JRC-000019, 
CAS number 67-56-1) and for carbon tetrachloride (JRC-000257, CAS number 56-23-5). 
According to the CLP classification, these chemicals should be classified in category 3 while with 
according to their average LD50 values, they would not be classified, with average LD50 > 2000 
mg/kg bodyweight. A probable reason for these differences could be due to volatility and loss of the 
test chemicals. 
 
Overall, the alternative methods, when used individually, showed an ability to predict LD50 with 
correlation coefficients in the range of 49% to 84%, and to classify into three toxicity groups with 
accuracies in the range 41% to 72%. Among the QSAR models, the best performing models were 
ToxSuite and TEST, with correlation coefficients of approximately 80% in LD50 prediction, and 
accuracies of approximately 70% in acute toxicity classification. The in vitro 3T3 NRU method, 
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based on the use of the Halle prediction model, had a correlation coefficient with LD50 of 
approximately 50%, and a classification accuracy of approximately 41%. 
 
When the QSAR models are combined in batteries, the overall accuracies were between 62% and 
74%. While these figures are not much higher than the individual QSAR models alone, the 
sensitivities for the different toxic classes are considerably higher. For example, the highest 
sensitivity for the most toxic class was 93% in one test combination compared to 67% for an 
individual QSAR model. The corresponding sensitivity figures for the other toxic classes are 87% 
compared to 81% (TC2) and 78% compared to 67% (TC3). On the other hand, the differences 
between the specificities for the different toxic classes are relatively small.  The highest specificity 
for the most toxic class is 97% for a test combination compared to 95% for an individual QSAR 
model. The highest specificities in other toxic classes are 72% compared to 70% (TC2) and 100% 
compared to 95% (TC3) 
 
When the alternative methods are used in a stepwise testing strategy the overall accuracy could 
reach 76%. Different test combinations can be optimised according to the end-users requirements: 
for example, to maximise overall accuracy, a suitable choice would be ITS3 (or ITS4, ITS10 
described in the Annex); to maximise sensitivity for toxic chemicals (at the expense of a higher 
false positive rate), a suitable choice would be ITS1 (or ITS2, ITS3, ITS9); whereas to maximise 
specificity for non-toxic chemicals (at the expense of a higher false negative rate), a suitable choice 
would be ITS5. 
 
On the basis of these results, it can be concluded that: 
 
d) the variability in LD50 values has an impact on classification, which means that the use of 
average LD50 values as a reference standard has to be used with care. A detailed analysis of 
the reference in vivo (LD50) data, to characterise the variability in these data and the impact 
on the ability to predict in vivo toxicity, is given elsewhere (Norlén et al., 2012). 
e) the in vitro test, 3T3 NRU used with the prediction model of Halle, has a lower predictive 
performance than the QSAR models. It is possible, however, that the in vitro test has a 
broader domain of applicability compared to the QSARs. It would be useful to explore 
whether the predictive performance of the in vitro system could also be increased by using 
an alternative prediction model. 
f) the overall accuracies for the test combinations or testing strategies are not much higher than 
the AMs used alone, but may be optimised in terms of overall predictivity, sensitivity and 
specificity according to the end-user’s requirements. 
 
 
A similar comparison study of acute toxicity classification into three categories by four QSAR 
models (ToxSuite, TOPKAT, TEST and ADMET Predictor) and one in vitro method (3T3 NRU 
using the prediction model of Halle) has to our knowledge not been done before. Sedykh and 
coworkers (Sedykh et al., 2011) adopted the same toxicity classification scheme with three 
categories when evaluating their own QSAR and hybrid models. In contrast to our study, Sedykh 
and coworkers made the simplification to exclude the “marginal” compounds (corresponding to 
TC2 chemicals) and hence made a clear binary classification of “toxic” and “nontoxic” chemicals. 
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They used k nearest neighbor classification and random forest QSAR methods to model LD50 data 
using chemicals descriptors alone or combined with biological descriptors derived from 
concentration-response quantitative high-throughput screening (qHTS) data. The performance of 
their hybrid models were shown to be superior to TOPKAT.  
 
In another study, Zhu et al. (2009a) divided the ZEBET (database on alternatives to animal 
experiments on the Internet) dataset into two groups, i.e. compounds with a good or a bad IC50/LD50 
correlation. The LD50 prediction accuracy of the resulting models proved superior to TOPKAT 
models applied to the same external test set of rodent acute toxicity data (RTECS chemicals). In 
addition to these local models, a number of QSAR models for rat oral acute toxicity have been 
developed using large datasets (global models) have been reported by Zhu and coworkers (Zhu et 
al., 2009b). These models were built by using a combinatorial QSAR modelling approach, 
including several sets of descriptors and employing several statistical modelling methods (e.g. 
nearest neighbour methods, the random forest method, and the FDA MDL QSAR method). 
Ultimately, consensus models were developed by averaging the predicted LD50 for every compound 
using all five models, which afforded higher prediction accuracy as compared to individual models. 
However, as a result of using a large number of descriptors, which are often sparsely populated, the 
multidimensional space defined by each of these models is complex and fragmented. As a result of 
the high complexity of the modelling procedure, these models are difficult to reproduce, even by a 
specialist, and thus they are not easily transferable and practically useful.  
 
A study by Raevsky and coworkers (Raevsky et al., 2010) proposed the so-called Arithmetic Mean 
Toxicity (AMT) modelling approach, which produces local models based on a k-nearest neighbors 
approach. The authors showed that LD50 values could be predicted with r2 values up to 0.78, 
depending on the selection of nearest neighbours (analogues), which is significantly better than the 
statistics associated with in vitro-in vivo correlation (typically r2 values less than 0.5). The approach 
is transparent and reproducible, but would need to be implemented in a software tool for ease of 
application. It can be thought of as an automated read-across approach. 
 
The results obtained in this study could be used as the basis for further investigations. For example, 
the Cooper statistics obtained for the AMs could be used as input parameters to explore Bayesian 
approaches for combining the results obtained by different methods. The results could also be used 
in the context of cost-benefit analyses in which the cost relates to the time, expense and difficulty of 
applying a method, and is compared with the benefit in terms of predictive ability and reduction in 
animal testing.  
 
Further studies, based on more extensive and high quality datasets (e.g. as generated by High 
Throughput Screening), would also be valuable in the search for optimal strategies for assessing 
acute toxicity. 
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6 Annex. List of 180 chemicals used in the study.  
 
Nr JRC nr CAS Chemical name SMILES1 
1 JRC-000002 103-90-2 acetaminophen CC(=O)Nc1ccc(cc1)O 
2 JRC-000003 50-78-2 acetylsalicylic acid CC(=O)Oc1ccccc1C(=O)O 
3 JRC-000004 5908-99-6 
atropine sulfate 
monohydrate 
C3C(CC2CCC3N2C)OC(C(c1ccccc1)CO)=O 
4 JRC-000005 58-08-2 caffeine Cn1cnc2c1c(=O)n(C)c(=O)n2C 
5 JRC-000006 298-46-4 carbamazepine NC(=O)N1c3ccccc3C=Cc2c1cccc2 
6 JRC-000007 64-86-8 colchicine COc3c(OC)cc2c(c3OC)c1ccc(c(=O)cc1C(CC2)NC(=O)C)OC 
7 JRC-000008 66-81-9 cycloheximide CC2CC(C)C(=O)C(C2)C(CC1CC(=O)NC(=O)C1)O 
8 JRC-000009 439-14-5 diazepam Clc3ccc2c(c3)C(=NCC(=O)N2C)c1ccccc1 
9 JRC-000010 20830-75-5 digoxin 
O=C3OCC(=C3)C4CCC8(C4(C)C(O)CC5C8CCC2C5(C)CCC(C2)OC
6CC(O)C(C(O6)C)OC7CC(O)C(C(O7)C)OC1CC(O)C(C(O1)C)O)O 
10 JRC-000011 67-63-0 propan-2-ol CC(O)C 
11 JRC-000012 121-75-5 malathion CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC 
12 JRC-000013 7487-94-7 mercury dichloride - 
13 JRC-000014 87-86-5 pentachlorophenol Clc1c(O)c(Cl)c(c(c1Cl)Cl)Cl 
14 JRC-000015 50-06-6 phenobarbital CCC2(C(=O)NC(=O)NC2=O)c1ccccc1 
15 JRC-000016 151-21-3 sodium lauryl sulfate CCCCCCCCCCCCOS(=O)(=O)O[Na] 
16 JRC-000017 1069-66-5 sodium valproate - 
17 JRC-000018 7720-78-7 ferrous sulfate - 
18 JRC-000019 67-56-1 methanol CO 
19 JRC-000020 10377-48-7 lithium salt - 
20 JRC-000021 58-55-9 theophylline Cn1c(=O)n(C)c2c(c1=O)ncn2 
21 JRC-000022 130-61-0 thioridazine hydrochloride N4(c2c(Sc3c4cccc3)ccc(c2)SC)CCC1N(CCCC1)C 
22 JRC-000023 81-81-2 warfarin CC(=O)CC(c3c(=O)oc2c(c3O)cccc2)c1ccccc1 
23 JRC-000024 67-66-3 chloroform ClC(Cl)Cl 
24 JRC-000025 54-85-3 isoniazid NNC(=O)c1ccncc1 
25 JRC-000026 75-09-2 dichloromethane ClCCl 
26 JRC-000027 50-63-5 
chloroquine 
bis(phosphate) 
c12c(nccc1NC(CCCN(CC)CC)C)cc(Cl)cc2 
27 JRC-000028 57-41-0 
phenytoin,  
5,5-diphenylhydantoin 
O=C2NC(=O)NC2(c3ccccc3)c1ccccc1 
28 JRC-000029 94-75-7 
2,4-dichlorophenoxyacetic 
acid 
OC(=O)COc1ccc(cc1Cl)Cl 
29 JRC-000030 57-33-0 pentobarbital sodium C1(C(=O)NC(=O)NC1=O)(C(CCC)C)CC 
30 JRC-000031 10262-69-8 maprotiline CNCCCC42CCC(c3c4cccc3)c1c2cccc1 
31 JRC-000032 3737-09-5 disopyramide CC(N(C(C)C)CCC(c2ccccn2)(c1ccccc1)C(=O)N)C 
32 JRC-000033 58-73-1 diphenhydramine CN(CCOC(c2ccccc2)c1ccccc1)C 
33 JRC-000034 533-45-9 clomethiazole Cc1ncsc1CCCl 
34 JRC-000035 6591-63-5 quinidine sulfate c12c(C(C3N4CC(C(C3)CC4)C=C)O)ccnc1ccc(c2)OC 
35 JRC-000036 76-57-3 codeine COc5ccc2c3c5OC1C43CCN(C(C2)C4C=CC1O)C 
                                                 
1The SMILES used in the fourth column describes the structure of chemical molecules used in the computational form 
for the QSAR software programs. The SMILES for inorganic compounds are omitted. 
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36 JRC-000037 69-09-0 
chlorpromazine 
hydrochloride 
N1(c2c(Sc3c1cccc3)ccc(c2)Cl)CCCN(C)C 
37 JRC-000038 123-63-7 paraldehyde CC1OC(C)OC(O1)C 
38 JRC-000039 144-55-8 sodium bicarbonate O=C(O)O 
39 JRC-000040 79-06-1 acrylamide NC(=O)C=C 
40 JRC-000041 50-00-0 formaldehyde C=O 
41 JRC-000042 75-07-0 acetaldehyde CC=O 
42 JRC-000043 107-02-8 acrolein C=CC=O 
43 JRC-000044 19774-82-4 
amiodarone 
hydrochloride 
c3(c2c(oc3CCCC)cccc2)C(=O)c1cc(c(c(c1)I)OCCN(CC)CC)I 
44 JRC-000045 51-63-8 
dexamphetamine 
sulphate 
c1(ccccc1)CC(C)N 
45 JRC-000046 71-43-2 benzene c1ccccc1 
46 JRC-000047 56-55-3 benz[a]anthracene c3ccc4c(c3)cc1c(c4)ccc2c1cccc2 
47 JRC-000048 59865-13-3 cyclosporine 
CC=CCC(C(C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O
)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C(=O)NC(C(=O)N(C(C(=
O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)
C 
48 JRC-000049 57-63-6 ethinylestradiol C#CC3(O)CCC4C3(C)CCC1C4CCc2c1ccc(c2)O 
49 JRC-000050 1095-90-5 methadone hydrochloride CCC(=O)C(c2ccccc2)(c1ccccc1)CC(N(C)C)C 
50 JRC-000051 64-75-5 tetracycline hydrochloride 
C1C2C(C(=C3C(c4c(cccc4C(C13)(C)O)O)=O)O)(C(C(C(N)=O)=C(C
2N(C)C)O)=O)O 
51 JRC-000052 341-69-5 ethanamine c1(C(c2ccccc2)OCCN(C)C)c(cccc1)C 
52 JRC-000053 152-11-4 verapamil hydrochloride c1(C(CCCN(CCc2cc(c(OC)cc2)OC)C)(C(C)C)C#N)cc(c(OC)cc1)OC 
53 JRC-000054 13292-46-1 rifamycin 
COC1C=COC5(C)Oc3c(C5=O)c2c(O)c(C=NN4CCN(CC4)C)c(c(c2c
(c3C)O)O)NC(=O)C(=CC=CC(C(C(C(C(C(C1C)OC(=O)C)C)O)C)O)C
)C 
54 JRC-000055 111-46-6 ethanol OCCOCCO 
55 JRC-000056 15663-27-1 platinum - 
56 JRC-000057 85-00-7 diquat dibromide BrN13CCCCC3C2N(CC1)(Br)CCCC2 
57 JRC-000058 303-47-9 ochratoxin A CC3OC(=O)c2c(C3)c(Cl)cc(c2O)C(=O)NC(C(=O)O)Cc1ccccc1 
58 JRC-000059 608-93-5 pentachlorobenzene Clc1cc(Cl)c(c(c1Cl)Cl)Cl 
59 JRC-000060 85-01-8 phenanthrene c3ccc2c(c3)c1ccccc1cc2 
60 JRC-000061 129-00-0 pyrene c1cc2ccc3c4c2c(c1)ccc4ccc3 
61 JRC-000062 118-74-1 
benzene, 1,2,3,4,5,6-
hexachloro- 
Clc1c(Cl)c(Cl)c(c(c1Cl)Cl)Cl 
62 JRC-000063 77182-82-2 glufosinate-ammonium P(=O)(CCC(C(=O)O)N)(C)O 
63 JRC-000064 51-21-8 5-fluorouracil Fc1cnc(=O)nc1=O 
64 JRC-000065 75-91-2 tert-butyl hydroperoxide OOC(C)(C)C 
65 JRC-000066 10108-64-2 cadmium chloride - 
66 JRC-000067 634-66-2 
1,2,3,4-
tetrachlorobenzene 
Clc1c(Cl)ccc(c1Cl)Cl 
67 JRC-000068 54-11-5 nicotine CN2CCCC2c1cccnc1 
68 JRC-000069 58-89-9 cyclohexane ClC1C(Cl)C(Cl)C(C(C1Cl)Cl)Cl 
69 JRC-000070 64-17-5 ethanol CCO 
70 JRC-000071 56-38-2 parathion CCOP(=S)(Oc1ccc(cc1)N(=O)=O)OCC 
71 JRC-000072 62-73-7 dichlorvos COP(=O)(OC=C(Cl)Cl)OC 
72 JRC-000073 57-47-6 physostigmine CNC(=O)Oc3ccc2c(c3)C1(C)CCN(C1N2C)C 
73 JRC-000074 7681-49-4 sodium fluoride - 
74 JRC-000075 1910-42-5 paraquat dichloride c1(c2ccn(H)(cc2)C)ccn(H)(cc1)C 
75 JRC-000076 56-81-5 glycerol OCC(CO)O 
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76 JRC-000077 68-12-2 N,N-dimethylformamide O=CN(C)C 
77 JRC-000078 549-18-8 
amitriptyline 
hydrochloride 
C1(c2c(CCc3c1cccc3)cccc2)=CCCN(C)C 
78 JRC-000079 107-21-1 ethylene glycol OCCO 
79 JRC-000080 108-95-2 phenol Oc1ccccc1 
80 JRC-000081 7647-14-5 sodium chloride - 
81 JRC-000082 1330-20-7 
benzene, dimethyl-, 
xylene 
- 
82 JRC-000083 151-50-8 potassium cyanide (K(CN)) - 
83 JRC-000084 52-86-8 haloperidol Fc2ccc(cc2)C(=O)CCCN3CCC(CC3)(O)c1ccc(cc1)Cl 
84 JRC-000085 318-98-9 2-propanol c12c(OCC(CNC(C)C)O)cccc1cccc2 
85 JRC-000086 1327-53-3 arsenic oxide (As2O3) - 
86 JRC-000087 7446-18-6 dithallium sulphate - 
87 JRC-000088 70-30-4 hexachlorophene Clc2cc(Cl)c(c(c2O)Cc1c(O)c(Cl)cc(c1Cl)Cl)Cl 
88 JRC-000089 56-75-7 chloramphenicol OCC(C(c1ccc(cc1)N(=O)=O)O)NC(=O)C(Cl)Cl 
89 JRC-000090 7447-40-7 potassium chloride - 
90 JRC-000091 302-17-0 chloral hydrate OC(C(Cl)(Cl)Cl)O 
91 JRC-000092 57-53-4 meprobamate CCCC(COC(=O)N)(COC(=O)N)C 
92 JRC-000093 57-24-9 strychnine O=C5CC7OCC=C3C4C7C2N5c6ccccc6C12CCN(C1C4)C3 
93 JRC-000094 77-21-4 glutethimide CCC2(CCC(=O)NC2=O)c1ccccc1 
94 JRC-000095 614-39-1 
procainamide 
hydrochloride 
c1(C(NCCN(CC)CC)=O)ccc(N)cc1 
95 JRC-000096 13410-01-0 selenic acid - 
96 JRC-000097 75-05-8 acetonitrile CC#N 
97 JRC-000098 51-42-3 
epinephrine hydrogen 
tartrate 
c1(cc(c(O)cc1)O)C(CNC)O 
98 JRC-000099 99-66-1 valproic acid CCCC(C(=O)O)CCC 
99 JRC-000106 90-72-2 
2,4,6-
tris(dimethylaminomethyl
)phenol 
CN(Cc1cc(CN(C)C)c(c(c1)CN(C)C)O)C 
100 JRC-000107 98-86-2 acetophenone CC(=O)c1ccccc1 
101 JRC-000108 141-97-9 butanoic acid CCOC(=O)CC(=O)C 
102 JRC-000109 100-97-0 
1,3,5,7-
Tetraazatricyclo[3.3.1.13,
7]decane 
C1N2CN3CN1CN(C2)C3 
103 JRC-000110 112-34-5 
ethanol, 2-(2-
butoxyethoxy)- 
CCCCOCCOCCO 
104 JRC-000111 106-51-4 
2,5-cyclohexadiene-1,4-
dione 
O=C1C=CC(=O)C=C1 
105 JRC-000112 2386-87-0 
7-
oxabicyclo[4.1.0]heptane-
3-carboxylic acid 
O=C(C3CCC4C(C3)O4)OCC1CCC2C(C1)O2 
106 JRC-000113 9005-64-5 polysorbate 20 
OCCOC(C1OC(CC1OCCO)OCCO)COCCOC(=O)CCCCCCCC=CCCC
CCCCC 
107 JRC-000114 105-39-5 
acetic acid, 2-chloro-, 
ethyl ester 
CCOC(=O)CCl 
108 JRC-000115 81-14-1 
4'-tert-butyl-2',6'-
dimethyl-3',5'-
dinitroacetophenone 
O=N(=O)c1c(C)c(C(=O)C)c(c(c1C(C)(C)C)N(=O)=O)C 
109 JRC-000116 91-53-2 ethoxyquin CCOc1ccc2c(c1)C(=CC(N2)(C)C)C 
110 JRC-000117 110-97-4 2-propanol CC(CNCC(O)C)O 
39 
 
 
Nr JRC nr CAS Chemical name SMILES 
111 JRC-000118 3926-62-3 
acetic acid, 2-chloro-, 
sodium salt (1:1) 
C(CCl)(O)=O 
112 JRC-000119 917-61-3 sodium cyanate [Na]OC#N 
113 JRC-000120 68515-48-0 
1,2-benzenedicarboxylic 
acid 
CCCCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCCC 
114 JRC-000121 101-72-4 1,4-benzenediamine CC(Nc2ccc(cc2)Nc1ccccc1)C 
115 JRC-000122 7778-80-5 potassium sulfate - 
116 JRC-000123 92-43-3 1-phenyl-3-pyrazolidone O=C2CCN(N2)c1ccccc1 
117 JRC-000124 1338-39-2 sorbitan CCCCCCCCCCCC(=O)OCC(C1OCC(C1O)O)O 
118 JRC-000125 60-00-4 edetic acid OC(=O)CN(CC(=O)O)CCN(CC(=O)O)CC(=O)O 
119 JRC-000126 357-57-3 
strychnidin-10-one, 2,3-
dimethoxy- 
COc5cc6c(cc5OC)N1C3C76CCN2C7CC4C3C(CC1=O)OCC=C4C2 
120 JRC-000127 120-82-1 benzene, 1,2,4-trichloro- Clc1ccc(c(c1)Cl)Cl 
121 JRC-000128 97-74-5 
tetramethylthiuram 
monosulphide 
CN(C(=S)SC(=S)N(C)C)C 
122 JRC-000129 95-50-1 1,2-dichlorobenzene Clc1ccccc1Cl 
123 JRC-000130 1034-01-1 octyl ester CCCCCCCCOC(=O)c1cc(O)c(c(c1)O)O 
124 JRC-000131 108-46-3 1,3-benzenediol Oc1cccc(c1)O 
125 JRC-000132 25646-77-9 ethanol OCCN(c1ccc(c(c1)C)N)CC 
126 JRC-000133 1314-13-2 zinc oxide (ZnO) - 
127 JRC-000134 109-16-0 2-propenoic acid O=C(C(=C)C)OCCOCCOCCOC(=O)C(=C)C 
128 JRC-000135 107-64-2 1-octadecanaminium CCCCCCCCCCCCCCCCCCN(H)(CCCCCCCCCCCCCCCCCC)(C)C 
129 JRC-000136 85-44-9 phthalic anhydride O=C1OC(=O)c2c1cccc2 
130 JRC-000137 79-94-7 
2,2',6,6'-tetrabromo-4,4'-
isopropylidenediphenol 
CC(c2cc(Br)c(c(c2)Br)O)(c1cc(Br)c(c(c1)Br)O)C 
131 JRC-000138 26523-78-4 
phenol, nonyl-, 1,1',1"-
phosphite 
CCCCCCCCCc2ccc(cc2)OP(Oc3ccc(cc3)CCCCCCCCC)Oc1ccc(cc1)
CCCCCCCCC 
132 JRC-000139 112-07-2 
ethanol, 2-butoxy-, 1-
acetate 
CCCCOCCOC(=O)C 
133 JRC-000140 121-87-9 
benzenamine, 2-chloro-4-
nitro- 
O=N(=O)c1ccc(c(c1)Cl)N 
134 JRC-000141 124-07-2 octanoic acid CCCCCCCC(=O)O 
135 JRC-000142 120-51-4 
benzoic acid, 
phenylmethyl ester 
O=C(c2ccccc2)OCc1ccccc1 
136 JRC-000143 131-17-9 
1,2-benzenedicarboxylic 
acid 
C=CCOC(=O)c1ccccc1C(=O)OCC=C 
137 JRC-000144 26761-40-0 
1,2-benzenedicarboxylic 
acid 
CC(CCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCC(C)C)C 
138 JRC-000145 122-99-6 ethanol, 2-phenoxy- OCCOc1ccccc1 
139 JRC-000146 102-71-6 ethanol, 2,2',2"-nitrilotris- OCCN(CCO)CCO 
140 JRC-000147 134-32-7 1-naphthalenamine Nc1cccc2c1cccc2 
141 JRC-000148 110-16-7 2-butenedioic acid (2Z)- OC(=O)C=CC(=O)O 
142 JRC-000149 10361-37-2 barium chloride (BaCl2) - 
143 JRC-000150 579-66-8 2,6-diethylaniline CCc1cccc(c1N)CC 
144 JRC-000151 302-27-2 
aconitane-3,8,13,14,15-
pentol 
COCC15CN(CC)C6C4(C5C(OC)C6C2(C7C4CC(C7OC(=O)c3ccccc3
)(C(C2O)OC)O)OC(=O)C)C(CC1O)OC 
145 JRC-000152 12125-02-9 
ammonium chloride 
((NH4)Cl) 
- 
40 
 
 
Nr JRC nr CAS Chemical name SMILES 
146 JRC-000153 7758-98-7 copper sulphate - 
147 JRC-000154 557-05-1 zinc distearate 
CCCCCCCCCCCCCCCCCC(=O)O[Zn]OC(=O)CCCCCCCCCCCCCCCC
C 
148 JRC-000155 102-76-1 
1,2,3-propanetriol, 1,2,3-
triacetate 
CC(=O)OC(COC(=O)C)COC(=O)C 
149 JRC-000156 103-11-7 
2-propenoic acid, 2-
ethylhexyl ester 
CCCCC(COC(=O)C=C)CC 
150 JRC-000157 100-52-7 benzaldehyde O=Cc1ccccc1 
151 JRC-000158 7779-90-0 
trizinc 
bis(orthophosphate) 
- 
152 JRC-000159 109-77-3 propanedinitrile N#CCC#N 
153 JRC-000160 866-84-2 tripotassium citrate C(CC(O)=O)(CC(O)=O)(C(O)=O)O 
154 JRC-000161 57-13-6 urea NC(=O)N 
155 JRC-000189 84-74-2 dibutyl phthalate CCCCOC(=O)c1ccccc1C(=O)OCCCC 
156 JRC-000235 71-55-6 1,1,1-trichloroethane CC(Cl)(Cl)Cl 
157 JRC-000236 89-57-6 benzoic acid Nc1ccc(c(c1)C(=O)O)O 
158 JRC-000237 54-62-6 L-glutamic acid 
OC(=O)CCC(C(=O)O)NC(=O)c3ccc(cc3)NCc1cnc2c(n1)c(N)nc(n2
)N 
159 JRC-000238 10043-35-3 boric acid - 
160 JRC-000239 55-98-1 busulfan CS(=O)(=O)OCCCCOS(=O)(=O)C 
161 JRC-000240 77-92-9 citric acid OC(=O)C(CC(=O)O)(CC(=O)O)O 
162 JRC-000241 76-87-9 fentin O[Sn](c2ccccc2)(c3ccccc3)c1ccccc1 
163 JRC-000242 84-66-2 diethyl phthalate CCOC(=O)c1ccccc1C(=O)OCC 
164 JRC-000243 298-04-4 phosphorodithioic acid CCSCCSP(=S)(OCC)OCC 
165 JRC-000244 115-29-7 endosulfan O=S3OCC2C(CO3)C1(C(C2(Cl)C(=C1Cl)Cl)(Cl)Cl)Cl 
166 JRC-000245 39515-41-8 
cyclopropanecarboxylic 
acid 
N#CC(c2cccc(c2)Oc3ccccc3)OC(=O)C1C(C1(C)C)(C)C 
167 JRC-000246 77-06-5 gibberellic acid 
OC(=O)C1C2C3(C4C51CC(=C)C(C5)(O)CC4)C=CC(C2(C)C(=O)O3
)O 
168 JRC-000247 50-21-5 lactic acid OC(=O)C(O)C 
169 JRC-000248 554-13-2 lithium carbonate - 
170 JRC-000249 103-85-5 phenyl-2-thiourea NC(=S)Nc1ccccc1 
171 JRC-000250 94-13-3 benzoic acid CCCOC(=O)c1ccc(cc1)O 
172 JRC-000251 7784-46-5 
arsenenous acid, sodium 
salt (1:1) 
- 
173 JRC-000252 7789-12-0 chromic acid (H2Cr2O7) - 
174 JRC-000253 7681-52-9 sodium hypochlorite - 
175 JRC-000254 62-76-0 
ethanedioic acid, sodium 
salt (1:2) 
[Na]OC(=O)C(=O)O[Na] 
176 JRC-000255 76-03-9 trichloroacetic acid OC(=O)C(Cl)(Cl)Cl 
177 JRC-000256 51-18-3 
tretamine, 
triethylenemelamine 
C2CN2c3nc(nc(n3)N4CC4)N1CC1 
178 JRC-000257 56-23-5 carbon tetrachloride ClC(Cl)(Cl)Cl 
179 JRC-000258 7758-99-8 cupric sulfate - 
180 JRC-000259 6385-62-2 
dipyrido[1,2-a:2',1'-
c]pyrazinium 
c3ccn2(H)c(c3)c1ccccn1(H)CC2 
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Abstract 
 
We have assessed the abilities of five alternative (non-animal) approaches to predict acute oral toxicity, a toxicological endpoint 
relevant to multiple pieces of legislation on chemicals and consumer products. In particular, we have investigated four QSAR 
models (ToxSuite, TOPKAT, TEST and ADMET Predictor) and one in vitro method (3T3 NRU). Based on a test set of in vitro and 
in vivo data for 180 compounds, we have characterized the predictive performance of each method when used alone (both for LD50 
prediction and acute toxicity classification into three categories), as well as multiple test combinations (batteries) and stepwise 
testing strategies (for acute toxicity classification into three categories). When used individually, the alternative methods showed an 
ability to predict LD50 with correlation coefficients in the range from 49% to 84%, and to classify into three toxicity groups with 
accuracies in the range from 41% to 72%. When the alternative methods were combined into batteries or testing strategies, the 
overall accuracy of prediction could reach 76%. We also illustrate how different combinations of methods can be used to optimize 
sensitivity or specificity. 
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policies with independent, evidence-based scientific and technical support throughout the whole policy 
cycle. 
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challenges while stimulating innovation through developing new standards, methods and tools, and 
sharing and transferring its know-how to the Member States and international community. 
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